Shenderov, E., Boudadi, K., Fu, W., Wang, H., Sullivan, R., Jordan, A., . . . Antonarakis, E. S. (2021). Nivolumab plus Ipilimumab, with or without Enzalutamide, in AR-V7-expressing Metastatic Castration-Resistant Prostate Cancer: A Phase-2 Nonrandomized Clinical Trial. Prostate.
Citação norma ChicagoShenderov, Eugene, et al. "Nivolumab Plus Ipilimumab, With or Without Enzalutamide, in AR-V7-expressing Metastatic Castration-Resistant Prostate Cancer: A Phase-2 Nonrandomized Clinical Trial." Prostate 2021.
Citação norma MLAShenderov, Eugene, et al. "Nivolumab Plus Ipilimumab, With or Without Enzalutamide, in AR-V7-expressing Metastatic Castration-Resistant Prostate Cancer: A Phase-2 Nonrandomized Clinical Trial." Prostate 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.